Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Efficacy and safety of direct oral anticoagulants (DOACs) for preventing primary and recurrent venous thromboembolism (VTE) in patients with cancer remain unclear. In this study, we conducted a systematic review to summarize the most up-to-date evidence from randomized controlled trials (RCTs). Our...

Full description

Bibliographic Details
Main Authors: Jie Zeng MSc, Xuhui Zhang MD, Gregory Y. H. Lip MD, Xiaochen Shu MD, Lehana Thabane PhD, Junzhang Tian MD, Guowei Li PhD, MSc, MBBS
Format: Article
Language:English
Published: SAGE Publishing 2019-05-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/1076029619853629

Internet

https://doi.org/10.1177/1076029619853629

Similar Items